These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9819824)

  • 1. [Characterization of structure and antigenic activity of lipopolysaccharides of genus Francisella].
    Maslova NN; Pavlovich NV; Sorokin VM; Zurabian VA
    Mol Gen Mikrobiol Virusol; 1998; (3):26-9. PubMed ID: 9819824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
    Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
    Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria].
    Aronova NV; Pavlovich NV
    Mol Gen Mikrobiol Virusol; 2001; (2):26-30. PubMed ID: 11449797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of lipopolysaccharide in toxicity of Francisella genus bacteria].
    Onoprienko NN; Pavlovich NV
    Mol Gen Mikrobiol Virusol; 2003; (3):25-8. PubMed ID: 12966923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the core part of the lipopolysaccharide O-antigen of Francisella novicida (U112).
    Vinogradov E; Perry MB
    Carbohydr Res; 2004 Jun; 339(9):1643-8. PubMed ID: 15183739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens.
    Thomas RM; Titball RW; Oyston PC; Griffin K; Waters E; Hitchen PG; Michell SL; Grice ID; Wilson JC; Prior JL
    Infect Immun; 2007 Jan; 75(1):371-8. PubMed ID: 17074846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative analysis of Francisella protein antigens].
    Rodionova IV; Meshcheriakova IS; Kormilitsyna MI
    Mol Gen Mikrobiol Virusol; 1997; (3):11-5. PubMed ID: 9297103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the heterogeneity of lipopolysaccharides of Ralstonia solanacearum].
    Vinars'ka NV; Varbanets' LD
    Mikrobiol Z; 2002; 64(6):12-20. PubMed ID: 12664545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization and serological specificities of lipopolysaccharides from Salmonella enterica serovar Gallinarum biovar Pullorum standard, intermediate and variant antigenic type strains.
    Brooks BW; Perry MB; Lutze-Wallace CL; Maclean LL
    Vet Microbiol; 2008 Jan; 126(4):334-44. PubMed ID: 17855026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunomodulating and antitoxic properties of preparations of lipopolysaccharides from representatives of the genus Francisella].
    Maslova NN; Pavlovich NV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):50-3. PubMed ID: 10852051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the lipopolysaccharide and beta-glucan of the fish pathogen Francisella victoria.
    Kay W; Petersen BO; Duus JØ; Perry MB; Vinogradov E
    FEBS J; 2006 Jul; 273(13):3002-13. PubMed ID: 16759227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The phosphatase activity in representatives of the genus Francisella].
    Tsimbalistova MV; Pavlovich NV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):10-3. PubMed ID: 9532678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The C antigen of Francisella tularensis].
    Sukhar' VV; Uraleva VS
    Mikrobiol Zh (1978); 1992; 54(2):42-6. PubMed ID: 1374833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Composition, structure, and biological properties of lipopolysaccharides from different strains of Pseudomonas syringae pv. atrofaciens].
    Zdorovenko GM; Zdorovenko EL; Varbanets LD
    Mikrobiologiia; 2007; 76(6):774-89. PubMed ID: 18297868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of antigenic determinants of Yersinia pestis lipopolysaccharide using monoclonal antibodies].
    Fedorova VA; Devdariani ZL
    Mol Gen Mikrobiol Virusol; 1998; (3):22-6. PubMed ID: 9819823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease.
    Hollis DG; Weaver RE; Steigerwalt AG; Wenger JD; Moss CW; Brenner DJ
    J Clin Microbiol; 1989 Jul; 27(7):1601-8. PubMed ID: 2671019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type IV pili-mediated secretion modulates Francisella virulence.
    Hager AJ; Bolton DL; Pelletier MR; Brittnacher MJ; Gallagher LA; Kaul R; Skerrett SJ; Miller SI; Guina T
    Mol Microbiol; 2006 Oct; 62(1):227-37. PubMed ID: 16987180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112).
    Vinogradov E; Conlan WJ; Gunn JS; Perry MB
    Carbohydr Res; 2004 Feb; 339(3):649-54. PubMed ID: 15013402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS.
    Dueñas AI; Aceves M; Orduña A; Díaz R; Sánchez Crespo M; García-Rodríguez C
    Int Immunol; 2006 May; 18(5):785-95. PubMed ID: 16574669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine.
    Pierson T; Matrakas D; Taylor YU; Manyam G; Morozov VN; Zhou W; van Hoek ML
    J Proteome Res; 2011 Mar; 10(3):954-67. PubMed ID: 21138299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.